Yang Qian, Feng Fan, Zhang Fan, Wang Chunping, Lu Yinying, Gao Xudong, Zhu Yunfeng, Yang Yongping
College of Clinical Medicine, Second Military Medical University, Shanghai 200433, PR China.
Cell Signal. 2013 Dec;25(12):2652-60. doi: 10.1016/j.cellsig.2013.08.029. Epub 2013 Sep 4.
Long interspersed nucleotide element (LINE)-1 ORF-1p is encoded by the human pro-oncogene LINE-1. It is involved in the development and progression of several human carcinomas, such as hepatocellular carcinoma and lung and breast cancers. The hepatocyte growth factor (HGF)/ETS-1 signaling pathway is involved in regulation of cancer cell proliferation, metastasis and invasion. The biological function of the interaction between LINE-1 ORF-1p and the HGF/ETS-1 signaling pathway in regulation of human breast cancer proliferation remains largely unknown. Here, we showed that LINE-1 ORF-1p enhanced ETS-1 transcriptional activity and increased expression of downstream genes of ETS-1. Interaction between ETS-1 and LINE-1 ORF-1p was identified by immunoprecipitation assays. LINE-1 ORF-1p modulated ETS-1 activity through cytoplasm/nucleus translocation and recruitment to the ETS-1 binding element in the MMP1 gene promoter. We also showed that LINE-1 ORF-1p promoted proliferation and anchorage-independent growth of MDA-MB-231 breast cancer cells. By investigating a novel role of the LINE-1 ORF-1p in the HGF/ETS-1 signaling pathway and MDA-MB-231 cells, we demonstrated that LINE-1 ORF-1p may be a novel ETS-1 coactivator and molecular target for therapy of human triple negative breast cancer.
长散在核苷酸元件(LINE)-1开放阅读框1蛋白(ORF-1p)由人类原癌基因LINE-1编码。它参与了多种人类癌症的发生和发展,如肝细胞癌、肺癌和乳腺癌。肝细胞生长因子(HGF)/ETS-1信号通路参与癌细胞增殖、转移和侵袭的调控。LINE-1 ORF-1p与HGF/ETS-1信号通路相互作用在调控人类乳腺癌增殖中的生物学功能仍 largely未知。在此,我们表明LINE-1 ORF-1p增强了ETS-1的转录活性并增加了ETS-1下游基因的表达。通过免疫沉淀实验鉴定了ETS-1与LINE-1 ORF-1p之间的相互作用。LINE-1 ORF-1p通过细胞质/细胞核转位以及募集到基质金属蛋白酶1(MMP1)基因启动子中的ETS-1结合元件来调节ETS-1活性。我们还表明LINE-1 ORF-1p促进了MDA-MB-231乳腺癌细胞的增殖和非锚定依赖性生长。通过研究LINE-1 ORF-1p在HGF/ETS-1信号通路和MDA-MB-231细胞中的新作用,我们证明LINE-1 ORF-1p可能是一种新型的ETS-1共激活因子以及人类三阴性乳腺癌治疗的分子靶点。